prikaz prve stranice dokumenta Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
  Download
PDF 66.75 KB
Professional paper - Editorial
Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
Croatian Medical Journal, 59 (2018), 3; 97-99. https://doi.org/10.3325/cmj.2018.59.97
Mikolašević, Ivana; Bokun, Tomislav; Filipec Kanižaj, Tajana

Cite this document

Mikolašević, I., Bokun, T. & Filipec Kanižaj, T. (2018). Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?. Croatian Medical Journal, 59. (3), 97-99. doi: 10.3325/cmj.2018.59.97

Mikolašević, Ivana, et al. "Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?." Croatian Medical Journal, vol. 59, no. 3, 2018, pp. 97-99. https://doi.org/10.3325/cmj.2018.59.97

Mikolašević, Ivana, Tomislav Bokun and Tajana Filipec Kanižaj. "Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?." Croatian Medical Journal 59, no. 3 (2018): 97-99. https://doi.org/10.3325/cmj.2018.59.97

Mikolašević, I., Bokun, T. and Filipec Kanižaj, T. (2018) 'Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?', Croatian Medical Journal, 59(3), pp. 97-99. doi: 10.3325/cmj.2018.59.97

Mikolašević I, Bokun T, Filipec Kanižaj T. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?. Croatian Medical Journal [Internet]. 2018 [cited 2024 November 12];59(3):97-99. doi: 10.3325/cmj.2018.59.97

I. Mikolašević, T. Bokun and T. Filipec Kanižaj, "Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?", Croatian Medical Journal, vol. 59, no. 3, pp. 97-99, 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:226771. [Accessed: 12 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma – where do we stand?
AuthorIvana Mikolašević
AuthorTomislav Bokun
AuthorTajana Filipec Kanižaj
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Almost 25% of all human cancers are located in the gastrointestinal tract (GIT), making it the dominant cancer-affected site. The reason for this could be constant GIT exposure to organ damage and chronic inflammation (1). Despite all medical breakthroughs, less than half of patients survive one year after the esophageal adenocarcinoma (EAC) diagnosis (2). Most malignancies, including most GIT malignancies, are preceded by precursor/premalignant lesions. Premalignant condition for EAC development is Barrett esophagus (BE), a disorder characterized by abnormal transformation of the squamous epithelium. BE is strongly associated with prolonged gastro-esophageal reflux of gastric and bile acids (1,3,4). Since patients with BE carry 30-40 times higher risk for EAC than general population, it is not surprising that in the last 10-20 years the research interest in BE has been growing (3)
Languageenglish
Publication typeProfessional paper - Editorial
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleCroatian Medical Journal
Numberingvol. 59, no. 3, pp. 97-99
p-ISSN0353-9504
e-ISSN1332-8166
DOIhttps://doi.org/10.3325/cmj.2018.59.97
URN:NBNurn:nbn:hr:184:226771
Publication2018
Document URLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045895/
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) icon
Created on2022-03-22 13:34:07